Pfizer
American multinational pharmaceutical and biotechnology corporation
A leading research-based biopharmaceutical company that develops medications and vaccines.
MoreLatest News & Reports
Latest News
5Media Resources | Pfizer
This page provides a summary of recent company news, including FDA approvals for COVID-19 vaccines and updates on the company's research pipeline for various medical treatments.
Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance
Pfizer reported its second-quarter 2026 financial results, highlighting 18% operational revenue growth from launched and acquired products and an increase in its full-year revenue guidance.
Pfizer targets $2.5bn more in cost savings
Pfizer has announced an additional $2.5 billion in cost-cutting initiatives to be realized between 2027 and 2029, following a major restructuring effort that began in 2023.
Pfizer appoints chief digital officer in boardroom shakeup
As part of a broader executive team reorganization, Pfizer has appointed Lidia Fonseca as its new chief digital and technology officer to enhance the company's digital capabilities in R&D and business processes.
Pfizer CEO Warns China May Follow US To Limit Biotech Deals
Pfizer CEO Albert Bourla has expressed concerns that China might implement restrictions on biotech dealmaking similar to those recently introduced in the United States.
Rate This
once per dayRating Insights
No ratings yet. Be the first to rate this subject and start the trend.
Rating Over Time
Comments
0Create a free account to share your thoughts
No comments yet. Be the first to share your thoughts!
